PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

191 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
121.
Metzeler, K.H.* et al.: An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia. Blood 112, 4193-4201 (2008)
122.
Rastelli, J. et al.: LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1. Blood 111, 1448-1455 (2008)
123.
Rawat, V.P.S. et al.: Overexpression of CDX2 perturbs HOX gene expression in murine progenitors depending on its N-terminal domain and is closely correlated with deregulated HOX gene expression in human acute myeloid leukemia. Blood 111, 309-319 (2008)
124.
Wies, E.* et al.: The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells. Blood 111, 320-327 (2008)
125.
Dorn, T.* et al.: RhoH is important for positive thymocyte selection and T-cell receptor signaling. Blood 109, 2346-2355 (2007)
126.
Mancao, C. & Hammerschmidt, W.: Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival. Blood 110, 3715-3721 (2007)
127.
Scheich, F.* ; Duyster, J.* ; Peschel, C.* & Bernhard, H.: The immunogenicity of Bcr-Abl expressing dendritic cells is dependent on the Bcr-Abl kinase activity and dominated by Bcr-Abl regulated antigens. Blood 110, 2556-2560 (2007)
128.
Schuster, I.G. et al.: Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignancies. Blood 110, 2931-2939 (2007)
129.
Tschoep, K.E.* & Nößner, E.: Understand tolerogenic dendritic cells. Blood 109, 3616 (2007)
130.
Vempati, S. et al.: Arginine 595 is duplicated in patients with acute leukemias carrying internal tandem duplications of FLT3 and modulates its transforming potential. Blood 110, 686-694 (2007)
131.
Cattoretti, G.* et al.: Nuclear and cytoplasmic AID in extrafollicular and germinal center B cells. Blood 107, 3967-3975 (2006)
132.
El-Maarri, O.* et al.: Lack of F8 mRNA: A novel mechanism leading to hemophilia A. Blood 107, 2759-2765 (2006)
133.
Hofer, S.* et al.: Dendritic cells regulate T-cell deattachment through the integrin-interavting protein CYTIP. Blood 107, 1003-1009 (2006)
134.
Kzhyshkowska, J.* et al.: Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway. Blood 107, 3221-3228 (2006)
135.
le Clorennec, C.* et al.: EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: Role of NF-kB, STAT1 and p53. Blood 107, 2070-2078 (2006)
136.
Mohan, J.* et al.: Epstein-Barr virus nuclear antigen 2 induces FcRH5 expression through CBF1. Blood 107, 4433-4439 (2006)
137.
Quintanilla-Martinez, L. et al.: NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein beta in ALK-positive anaplastic large cell lymphoma. Blood 108, 2029-2036 (2006)
138.
Reindl, C. et al.: Point mutations in the juxtamembrane domain of FLT define a new class of activating mutations in AML. Blood 107, 3700-3707 (2006)
139.
Rudelius, M.* et al.: Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma. Blood 108, 1668-1676 (2006)
140.
Schnittger, S.* et al.: KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free overall survival. Blood 107, 1791-1799 (2006)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... ▶▶ ▶▮